Axa S.A. Ocular Therapeutix, Inc Transaction History

Axa S.A.

$33.1 Billion
Q2 2024

A detailed history of Axa S.A. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Axa S.A. holds 638,665 shares of OCUL stock, worth $5.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

638,665

Previous 638,305 0.06%

Holding current value

$5.54 Million

Previous $5.81 Million 24.79%

% of portfolio

0.01%

Previous 0.02%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $1,512 - $3,128	360 Added 0.06%	638,665 $4.37 Million
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $689 - $1,956	179 Added 0.03%	638,305 $5.81 Million
Q4 2023 Jul 16, 2024	SELL	$2.08 - $4.52 $372 - $809	-179 Reduced 0.03%	638,126 $2.85 Million
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $2,304 - $5,008	-1,108 Reduced 0.17%	638,126 $2.85 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $516,008 - $828,243	164,334 Added 34.6%	639,234 $2.01 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $2.18 Million - $3.63 Million	474,900 New	474,900 $2.45 Million

Others Institutions Holding OCUL

# of Institutions

151

Shares Held

136M

Call Options Held

86.4K

Put Options Held

263K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account